Gender differences in rhGH-induced changes in body composition in GH-deficient adults

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4161-4165

  Span, Jan P T ^a   Pieters, Gerlach F F M ^a   Sweep, Fred G J ^a   Hermus, Ad R M M ^a   Smals, Anthony G H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BONE GROWTH; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; TOTAL BODY WATER;

EID: 0034853489     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.9.7815     Document Type: Article

References (15)

1. The effect of the human growth hormone on subcutaneous fat thickness in hyposomatotrophic and panhypopituitary dwarfs
2. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with growth hormone deficiency: Gender specific metabolic effects
3. Beneficial effects of growth hormone treatment in GH deficient adults
4. The effects of treatment with recombinant growth hormone on body composition and metabolism in adults with growth hormone deficiency
5. Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: A four months double blind placebo controlled study
6. Gender differences in IGF-I response to growth hormone (GH) in GH deficient adults: Role of estrogen replacement
7. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement
8. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
9. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency
10. The Australian multi-center trial of growth hormone (GH) treatment in GH-deficient adults
11. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults
12. A switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency
13. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy
14. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH deficient adults
15. Plasma IGF1 is a useful marker of growth hormone deficiency in adults